Supriya Lifescience

Mumbai, India Founded: 2008 • Age: 18 yrs
Active pharmaceutical ingredients and intermediates are manufactured.
Annual revenue $79.6M Latest available
Total funding - Funding intelligence
Employees 1070 Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Supriya Lifescience

Supriya Lifescience is a company based in Mumbai (India) founded in 2008 by Satish Wagh. The company has 1,070 employees as of March 31, 2024. Supriya Lifescience offers products and services including APIs and FDF.

  • Headquarter Mumbai, India
  • Employees 1070 as on 31 Mar, 2024
  • Founders Satish Wagh
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Supriya Lifescience Limited
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
    $79.59 M (USD)
    21.91
    as on Mar 31, 2025
  • Net Profit
    $22.01 M (USD)
    57.8
    as on Mar 31, 2025
  • EBITDA
    $29.85 M (USD)
    50.66
    as on Mar 31, 2025
  • Latest Funding Round
  • Investors
  • Employee Count
    1070

    as on Mar 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Supriya Lifescience

Supriya Lifescience is a publicly listed company on the NSE with ticker symbol SUPRIYA in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NSE · Ticker: SUPRIYA · Sector: Health technology · India

Products & Services of Supriya Lifescience

Supriya Lifescience offers a comprehensive portfolio of products and services, including APIs and FDF.

Primary

Active pharmaceutical ingredients are manufactured and supplied for therapeutic uses in various diseases.

Finished dosage forms are developed and commercialized to address infections and other health conditions.

People of Supriya Lifescience

Headcount 200-500
Employee Profiles 6
Employee Profiles
People
Rajesh Joshi
General Manager
People
Rajeev Jain
Chief Executive Officer
People
Sreekant Sreedharan
General Manager
People
Krishna Raghunathan
Chief Financial Officer

Unlock access to complete

Funding Insights of Supriya Lifescience

Investments & Acquisitions by Supriya Lifescience

Investments

Financial Statements - Supriya Lifescience

Supriya Lifescience Comparisons

+
Add Comparison
Available on Premium

Competitors of Supriya Lifescience

Latest news on Supriya Lifescience

Frequently Asked Questions about Supriya Lifescience

Supriya Lifescience was founded in 2008.

Supriya Lifescience is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

As of Mar 31, 2024, the latest employee count at Supriya Lifescience is 1,070.

Annual revenue of Supriya Lifescience is $79.59M as on Mar 31, 2025.

Supriya Lifescience was established in 2008 and is based in Mumbai, India. Operations are centered on the production of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates within the healthcare sector. Manufacturing processes are conducted to support pharmaceutical supply chains. The company is led by founder Satish Wagh. Focus remains on quality-controlled production for global markets, with activities aligned to regulatory standards in the industry.

Supriya Lifescience offers APIs and FDF.

Yes, Supriya Lifescience is publicly traded on NSE under the ticker symbol SUPRIYA.

The ticker symbol of Supriya Lifescience is SUPRIYA on NSE.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available